Navigation Links
Albireo Announces Positive Results in Patients With Chronic Idiopathic Constipation From a Phase IIb trial of A3309
Date:10/12/2010

rent dose levels (5, 10 and 15 mg orally once a day) of the investigational drug A3309 during an eight week trial. Analyses of the data show clinically meaningful and statistically significant improvement for patients treated with A3309 compared to placebo-treated patients. A3309 is a first-in-class IBAT inhibitor with minimal systemic exposure which is developed for the treatment of CIC and constipation-predominant irritable bowel syndrome (IBS-C).

The primary efficacy endpoint, change from baseline in spontaneous bowel movements (SBMs), showed a dose-dependent increase and highly significant results were obtained for the two highest dose levels. In addition, the secondary endpoints of effects on SBM and complete SBM (CSBM) frequencies were also dose dependent and statistically significant. Bloating and straining, important constipation symptoms, also decreased significantly during A3309 treatment. The effect of A3309 was rapid and a significantly higher proportion of the A3309-treated patients had a CSBM within 24 hours of the first administration. The beneficial effects were maintained over the eight week trial period.

"A3309 has a unique and novel mode of action which utilizes the body's physiologic processes to induce an increase in bowel movements. The results of this Phase IIb study show that A3309 has the potential to be an important therapeutic addition for patients with chronic constipation. I am sure that scientists and clinicians alike look forward to seeing further results with this exciting new compound" said William D. Chey, MD, Professor of Internal Medicine, University of Michigan, Ann Arbor.

"More than 30 million individuals suffer from CIC and IBS-C and the results of this Phase IIb trial further support the potential of A3309 to be an important treatment for these patients. The data in the trial presented today provide a solid base for moving forward into Phase III in 2011" said Hans Graffner, Chief Medical Officer of Albi
'/>"/>

SOURCE Albireo AB
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9

Related medicine technology :

1. Albireo Announces Positive Results From a Study With A3309 in Patients With Chronic Constipation
2. Gen-Probe Announces Webcast of Third Quarter 2010 Earnings Conference Call
3. Halozyme Therapeutics Announces Implementation of Development Focused Strategy
4. Pioneer® Surgical Technology, Inc. Announces Plans to Establish Manufacturing and Distribution Facility in Ireland
5. Webcast Alert: CEL-SCI Corp. (CVM) Announces the Biotech, Healthcare and Pharma Virtual Conference
6. IRIDEX Announces Commercial Availability of New Adjustable & Intuitive EndoProbe® Device for Eye Surgery
7. TriReme Medical Announces $17 Million Series D Financing
8. Warner Chilcott Announces FDA Approval of Next Generation Actonel
9. Arable Corporation Announces New Technology for Clinical Trial Industry
10. PharmaNet Development Group Announces Observational Research Survey
11. Auxilium Pharmaceuticals, Inc. Announces Initiation of XIAFLEX® Phase III Studies for Peyronies Disease
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/22/2014)... 22, 2014  Edwards Lifesciences Corporation (NYSE: ... heart valves and hemodynamic monitoring, announced that Edwards, Chairman ... as an expert panelist at the invitation of the ... to discuss medical device innovation at its hearing, "21 ... Development and Communication." "Edwards has five decades ...
(Date:7/22/2014)... -- Jazz Pharmaceuticals plc (Nasdaq: JAZZ ) today ... financial results on Tuesday, August 5, 2014, after the ... a live audio webcast immediately following the announcement at ... and financial update and discuss second quarter 2014 financial ... audio webcast via the Investors & Media section of ...
(Date:7/22/2014)... , July 22, 2014 Research ... "Cell Culture Market by Equipment, by Reagent, by ... their offering. http://photos.prnewswire.com/prnh/20130307/600769 ... organisms. Cell culture is one of the most important ... also the largest application segment of the cell culture ...
Breaking Medicine Technology:Edwards' CEO Invited To Address Congress On Opportunities To Revitalize Medical Device Innovation 2Jazz Pharmaceuticals to Report 2014 Second Quarter Financial Results on August 5, 2014 2Global Cell Culture (Bioreactor, Incubator, Centrifuge) Market - Forecast to 2018 2Global Cell Culture (Bioreactor, Incubator, Centrifuge) Market - Forecast to 2018 3
(Date:7/22/2014)... July 22, 2014 The 2014 ... the Ronald Reagan Building and International Trade Center ... Military Families and Civilian Communities,” will be held ... at 7:30 a.m.) and cohosted by the Military ... Defense Industrial Association (NDIA). USAA is the Executive ...
(Date:7/22/2014)... By Steven Reinberg ... -- Women who are obese during pregnancy may be more ... new review suggests. "We found that, compared with children ... overweight or obese during pregnancy had up to 20 to ... Erick Forno, an assistant professor of pediatrics at Children,s Hospital ...
(Date:7/22/2014)... of research at the University of Utah,s John A. ... Society of Eye Research (ISER) as the recipient of ... International Award in Retina Research., The award recognizes lifetime ... significant contribution to the understanding of vitreoretinal diseases or ... the ISER Biennial Meeting in San Francisco, where Marc ...
(Date:7/22/2014)... Washington DC (PRWEB) July 22, 2014 ... in USA, launched updated payment app for Forte Payment ... credit, debit and ACH payments on iPhone, iPod and ... 2013 and has been recently updated by SIMpalm. This ... support; app is currently supported on iOS 4.3 and ...
(Date:7/22/2014)... Ticket Down is a reliable source for ... in Landover, MD. There has never been a better time ... After the success of the American national soccer team at the ... One way that fans of the world’s sport will be able ... Guinness International Champions Cup. The tournament will kick off on July ...
Breaking Medicine News(10 mins):Health News:2014 Warrior-Family Symposium Focuses on Transitioning Forward 2Health News:2014 Warrior-Family Symposium Focuses on Transitioning Forward 3Health News:Obesity During Pregnancy Linked to Raised Asthma Risk in Kids 2Health News:Obesity During Pregnancy Linked to Raised Asthma Risk in Kids 3Health News:University of Utah researcher Robert Marc receives Paul Kayser International Award 2Health News:SIMpalm Launched Updated Forte Mobile Payment App on iPhone and iPad for Its Client 2Health News:SIMpalm Launched Updated Forte Mobile Payment App on iPhone and iPad for Its Client 3Health News:Manchester United vs. Inter Milan Tickets Fedex Field Landover: Ticket Down Slashes Ticket Prices for Inter Milan ManU International Champions Cup Match in Washington, DC 2Health News:Manchester United vs. Inter Milan Tickets Fedex Field Landover: Ticket Down Slashes Ticket Prices for Inter Milan ManU International Champions Cup Match in Washington, DC 3
... 9 Human Resources oversees an,organization,s biggest expense ... in some of a company,s biggest cost drivers, ... services can translate into significant,savings. To help ... LLC has published a comprehensive report containing more ...
... Day of Spa Services to Ten Breast Cancer Patients ... -Other Area Businesses Offer Freebies Too-, ... honor,of Breast Cancer Awareness Month, ten special breast cancer patients ... of luxurious spa,services for free. Afterward, the patients and their ...
... Oct. 9 Green Pet Products, an ... litter/bedding products,announces the development and introduction of ... products. (Photo: http://www.newscom.com/cgi-bin/prnh/20071009/CLTU089 ) ... content.,Addressing growing concerns over this microbiological content ...
... for Ozone Laundry and Energy Efficient Lighting Upgrades ... ... Oct. 9 National,Energy Services Company, Inc. (OTC Bulletin Board: NEGS), today ... and,Energy Efficient Lighting Upgrades. Golden Living skilled nursing,facilities in Indiana and California ...
... scientists, led by mathematicians, has taken on the challenge ... work will radically improve our understanding of the human ... on it to have a common reference point and ... Sciences Research Council (BBSRC), will investigate how the different ...
... COLUMBIA, Mo. Mr. Jones has chronic back pain. He ... because of the pain. He cannot lose weight because the ... in a publication by a University of Missouri-Columbia occupational therapy ... more than just a pill. , Some of the ...
Cached Medicine News:Health News:HR Under the Microscope: Metrics to Drive Costs Down Across HR Functions 2Health News:Breast Cancer Survivors Treated to a Day of Luxury for Breast Cancer Awareness Month 2Health News:Green Pet Products Introduces a New, Innovative Process to the Small Animal and Bird Litter/Bedding Category 2Health News:National Energy Services Receives Repeat Orders From Golden Living and Cathedral Rock Skilled Nursing Facilities 2Health News:Mathematicians help unlock secrets of the immune system 2Health News:More than a pill: Complementary medicine can help with chronic pain 2
Markham-Meyerding Hemilaminectomy Retractors, self-retaining, Right....
Panther Universal Spinal Retractor System...
Posterior Lumbar Retractor System ideally suited for spinal fixation, laminectomy, PLIF procedures. This system brings microdiscectomy to multi-level reconstruction....
... dense corticocancellous allografts comprised of ... structural integrity while allowing immediate ... allografts are available in Lordotic ... are processed from donor vertebral ...
Medicine Products: